There is no excerpt because this is a protected post.
Latest articles
Recommending Privately Developed FemTech in Healthcare Part 2: Understanding Healthcare Professionals’ Responsibilities
By Anna Nelson, Maria Tzanou and Tsachi Keren-Paz In the previous blog, we introduced the issues associated with healthcare professionals (HCPs) recommending privately-developed FemTech apps. In this second blog, we turn our attention to regulatory considerations associated with this practice. There are two distinct questions which could be asked here: (1) whether HCPs should recommend […]
Recommending Privately-Developed FemTech in Healthcare Part 1: Promises and Pitfalls
By Anna Nelson, Maria Tzanou and Tsachi Keren-Paz Introduction FemTech refers to apps and wearable devices (eg. smart breast pumps and bluetooth-enabled fertility monitors) purporting to empower women and non-binary users to manage their sexual, gynaecological and reproductive health. During their recent review of the data practices of period and fertility tracking apps, the […]
Creating a consolidated EMAH (Early Medical Abortion at Home) medication pack: What has the impact been?
By Nathan Burley Background Up to seven medicines are provided for an early medical abortion, similar to the amount supplied after a heart attack. Abortifacients, analgesia, an anti-emetic, contraception and an antibiotic could be supplied, with each attendance resulting in at least four packs being given. Clinics providing this service may store a variety […]
Breaking Barriers: Japan’s market test of emergency contraceptive pills and their intermediate results
By Hayase Hakariya The Japanese government finally initiated a market test to sell emergency contraceptive pills (ECPs), levonorgestrel (approved in 2011 in Japan), or its generic product, at the designated pharmacies on 28th November 2023. This has been achieved through the long-lasting 6-year endeavours by individuals or voluntary groups to voice easier access for […]
Defending the use of the term ‘obstetric violence’
By Ezio Di Nucci Here I defend ’obstetric violence’: not the practice, but its name – and more generally the idea that some obstetric practices deserve to be called acts of violence, contrary to what has recently been argued. This question is relevant beyond sexual and reproductive health: what is at stake is the very […]
The UK 2nd Conviction against Female Genital Mutilation (FGM)
By Juliet Albert On the 26th of October 2023 the Crown Prosecution Service convicted a woman of trafficking a three-year-old British child to Kenya to be subjected to FGM. The offence took place in 2006. Nine years later (in 2015), the victim confided in a schoolteacher and the police were subsequently informed. This is […]
Should we abolish ‘Sexual and Reproductive Health’?
By Ezio De Nucci Should we abolish ‘Sexual and Reproductive Health (SRH)? This provocative question might sound odd, especially after the US Supreme Court scrapped the federal right to abortion. Surely, we need more focus on ‘sexual and reproductive health’, not less! But actually, the issue is not as simple, especially after distinguishing between […]
Contraception prescribing during the COVID-19 pandemic – opportunities and challenges
By Malcolm Moffat, Tanha Begum, Emer Cullen & Judith Rankin When the COVID-19 pandemic began almost four years ago, few of us could have predicted the profound and enduring impact that the events of 2020 and 2021 would have on all our lives. Not least among those impacts were the effects that lockdown restrictions […]
Application of a novel abortion care quality measurement tool (ACQTool) in Bangladesh
By Laura E Jacobson, Sarah E. Baum, Erin Pearson, Rezwana Chowdhury, Nirali M. Chakraborty, Julia M. Goodman, Caitlin Gerdts, & Blair G. Darney Measuring and improving quality of care is an essential part of ensuring safe and effective health services; however, until recently measuring the quality of abortion care has been hampered by a lack of shared definitions […]